Effects of Augmented-reality Based Mirror Therapy on Sensorimotor Function of Upper Extremity
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Stroke
- Sponsor
- National Cheng-Kung University Hospital
- Enrollment
- 48
- Locations
- 1
- Primary Endpoint
- Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
In the proposed study, the investigators assumed that mirror therapy combined with augmented reality technology will provide a better treatment effects than traditional mirror therapy for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either augmented reality based mirror therapy, mirror therapy or traditional occupational therapy on the upper extremity function and brain activity of the stroke patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Clinical diagnosis of stroke with unilateral side involved;
- •A score of Mini-mental state examination greater than 24 for proving higher mental function
- •Time of onset \> 6 months before treatment begins; and
- •Premorbid right-handedness.
Exclusion Criteria
- •Severe vision impairment;
- •Major cognitive-perceptual deficit;
- •Other brain disease.
Outcomes
Primary Outcomes
Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test
Time Frame: baseline, 9 weeks and 21 weeks
Each item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.
Secondary Outcomes
- Change in the result of Box and blocks test(baseline, 9 weeks and 21 weeks)
- Change in the result of Motor Activity Log(baseline, 9 weeks and 21 weeks)
- Change in the result of Modified Ashworth scale (MAS)(baseline, 9 weeks and 21 weeks)
- Change in the result of Semmes-Weinstein monofilament (SWM) test(baseline, 9 weeks and 21 weeks)